Today
+1.39%
5 Days
+5.64%
1 Month
+14.27%
6 Months
-31.10%
Year to Date
-46.35%
1 Year
-50.40%
• Intuitive Surgical shares rose due to increased global procedure volumes and institutional demand. • Stable hospital capital expenditure and recurring revenue models support the company’s financial growth. • Analysts maintain a Buy rating with an average price target of $480.08.
• ResMed reported strong recurring revenue from its AirSense platform and software ecosystem. • Clinical insights suggest GLP-1 drugs increase sleep apnea diagnosis rates and patient engagement. • ResMed solidified market share as its primary competitor faces ongoing regulatory constraints.
• Capital rotated from defensive healthcare stocks into higher-beta growth sectors in June. • Medtronic’s share price declined following disappointing fiscal 2027 forward-looking guidance. • FTSE Russell index reconstitution and ex-dividend adjustments increased stock trading volatility.
• Stryker stock declined due to an ex-dividend price adjustment of 88 cents per share. • Russell index reconstitution forced passive funds to sell large volumes of Stryker shares. • Investor sentiment is pressured by concerns regarding the company’s high price-to-earnings valuation.
• Federal court ruled in favor of Stryker regarding its OptaBlate patent infringement dispute. • Stryker launched new surgical products and expanded Mako robotic system adoption globally. • Strong elective procedure demand supports Stryker's full-year earnings guidance and revenue visibility.
• Agilent reported strong fiscal Q2 2026 results, exceeding expectations. • Company raised fiscal 2026 profit and revenue guidance. • Analysts upgraded ratings and price targets following results.


| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.49% |
| Fidelity Management & Research Company LLC | 5.85% |
| BlackRock Institutional Trust Company, N.A. | 5.40% |
| State Street Investment Management (US) | 4.43% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 51.83% |
| Investment Advisor/Hedge Fund | 26.29% |
| Hedge Fund | 6.11% |
| Pension Fund | 3.03% |
Related Instruments
Popular Instruments